Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications

Purpose: The C-X-C chemokine receptor 4 (CXCR4) is highly expressed in many subtypes of cancers, notably in several kidney-based malignancies. We synthesized, labeled, and assessed a series of radiotracers based on a previous high contrast PET imaging radiopharmaceutical [⁶⁸Ga]Ga-BL02, wi...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Daniel Kwon, Zhengxing Zhang, Jutta Zeisler, Hsiou-Ting Kuo, Kuo-Shyan Lin, Francois Benard
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-07-01
Sarja:	Pharmaceutics
Aiheet:	positron emission tomography oncology CXCR4 pharmacokinetics nuclear medicine
Linkit:	https://www.mdpi.com/1999-4923/14/7/1502
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!